APA

Stevens K. N., Wang X., Fredericksen Z., Pankratz V. S., Greene M. H., Andrulis I. L., Thomassen M., Caligo M., Nathanson K. L., Jakubowska A., Osorio A., Hamann U., Godwin A. K., Stoppa-Lyonnet D., Southey M., Buys S. S., Singer C. F., Hansen T. V. O., Arason A., Offit K., Piedmonte M., Montagna M., Imyanitov E., Tihomirova L., Sucheston L., Beattie M., Neuhausen S. L., Szabo C. I., Simard J., Spurdle A. B., Healey S., Chen X., Rebbeck T. R., Easton D. F., Chenevix-Trench G., Antoniou A. C. & Couch F. J. (20130523). Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers. : Breast cancer research and treatment.

Chicago

Stevens Kristen N, Wang Xianshu, Fredericksen Zachary, Pankratz Vernon S, Greene Mark H, Andrulis Irene L, Thomassen Mads, Caligo Maria, Nathanson Katherine L, Jakubowska Anna, Osorio Ana, Hamann Ute, Godwin Andrew K, Stoppa-Lyonnet Dominique, Southey Melissa, Buys Saundra S, Singer Christian F, Hansen Thomas V O, Arason Adalgeir, Offit Kenneth, Piedmonte Marion, Montagna Marco, Imyanitov Evgeny, Tihomirova Laima, Sucheston Lara, Beattie Mary, Neuhausen Susan L, Szabo Csilla I, Simard Jacques, Spurdle Amanda B, Healey Sue, Chen Xiaoqing, Rebbeck Timothy R, Easton Douglas F, Chenevix-Trench Georgia, Antoniou Antonis C and Couch Fergus J. 20130523. Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers. : Breast cancer research and treatment.

Harvard

Stevens K. N., Wang X., Fredericksen Z., Pankratz V. S., Greene M. H., Andrulis I. L., Thomassen M., Caligo M., Nathanson K. L., Jakubowska A., Osorio A., Hamann U., Godwin A. K., Stoppa-Lyonnet D., Southey M., Buys S. S., Singer C. F., Hansen T. V. O., Arason A., Offit K., Piedmonte M., Montagna M., Imyanitov E., Tihomirova L., Sucheston L., Beattie M., Neuhausen S. L., Szabo C. I., Simard J., Spurdle A. B., Healey S., Chen X., Rebbeck T. R., Easton D. F., Chenevix-Trench G., Antoniou A. C. and Couch F. J. (20130523). Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers. : Breast cancer research and treatment.

MLA

Stevens Kristen N, Wang Xianshu, Fredericksen Zachary, Pankratz Vernon S, Greene Mark H, Andrulis Irene L, Thomassen Mads, Caligo Maria, Nathanson Katherine L, Jakubowska Anna, Osorio Ana, Hamann Ute, Godwin Andrew K, Stoppa-Lyonnet Dominique, Southey Melissa, Buys Saundra S, Singer Christian F, Hansen Thomas V O, Arason Adalgeir, Offit Kenneth, Piedmonte Marion, Montagna Marco, Imyanitov Evgeny, Tihomirova Laima, Sucheston Lara, Beattie Mary, Neuhausen Susan L, Szabo Csilla I, Simard Jacques, Spurdle Amanda B, Healey Sue, Chen Xiaoqing, Rebbeck Timothy R, Easton Douglas F, Chenevix-Trench Georgia, Antoniou Antonis C and Couch Fergus J. Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers. : Breast cancer research and treatment. 20130523.